Insider · CIK 0001486519

Johnston David Brannon

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001486519

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-06-06	ImmunoGen, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$3.05	+$30.5K	190,690
2018-06-06	ImmunoGen, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$11.02	−$110K	180,690
2018-06-06	ImmunoGen, Inc.Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	$3.05	−$30.5K	90,000
2018-03-15	ImmunoGen, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	$3.05	+$30.5K	190,690
2018-03-15	ImmunoGen, Inc.S Sale	Chief Financial Officer	SSale	−10K sh	$11.53	−$115K	180,690
2018-03-15	ImmunoGen, Inc.Stock option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	$3.05	−$30.5K	100,000
2018-02-21	ImmunoGen, Inc.S Sale	Chief Financial Officer	SSale	−21.1K sh	$10.87	−$229K	180,690
2018-02-15	ImmunoGen, Inc.Stock option (right to buy)A Award	Chief Financial Officer	AAward	+257K sh	$10.65	+$2.73M	256,500
2017-02-21	ImmunoGen, Inc.A Award	Chief Financial Officer	AAward	+192K sh	$2.47	+$474K	201,750
2016-11-02	ImmunoGen, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.70	+$17K	10,000
2016-07-18	ImmunoGen, Inc.Stock option (right to buy)A Award	Chief Financial Officer	AAward	+110K sh	$3.05	+$336K	110,000
2015-09-17	ImmunoGen, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$10.79	+$53.9K	5,000
2015-09-17	ImmunoGen, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$15.00	−$75K	0
2015-09-17	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	$10.79	−$53.9K	90,000
2015-08-03	ImmunoGen, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$10.79	+$53.9K	5,000
2015-08-03	ImmunoGen, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$17.04	−$85.2K	0
2015-08-03	ImmunoGen, Inc.Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	$10.79	−$53.9K	95,000
2015-07-13	ImmunoGen, Inc.Stock option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	$16.72	+$1.67M	100,000
2014-07-17	ImmunoGen, Inc.Stock option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	$10.79	+$1.08M	100,000
2013-10-02	AVEO PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−52.2K sh	—	—	46,837
2013-06-26	AVEO PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	−40K sh	—	—	95,943
2013-06-26	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Chief Financial Officer	AAward	−120K sh	—	—	120,000
2013-03-14	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,061 sh	$7.34	−$7,784.239	55,943
2013-01-28	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,150 sh	$7.77	−$8,936.765	57,004
2013-01-24	AVEO PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+32.5K sh	—	—	58,154
2013-01-24	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Chief Financial Officer	AAward	+32.5K sh	—	—	32,500
2012-09-13	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,386 sh	$10.60	−$14.7K	24,593
2012-06-06	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15K sh	$5.60	+$84K	40,154
2012-06-06	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−15K sh	$12.21	−$183K	25,154
2012-06-06	AVEO PHARMACEUTICALS, INC.Employee Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	150,000
2012-01-31	AVEO PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+19.7K sh	—	—	25,154
2012-01-31	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Chief Financial Officer	AAward	+33.5K sh	—	—	33,500
2012-01-26	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,107 sh	$13.37	−$14.8K	5,454
2011-12-01	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+1,000 sh	$5.60	+$5,600	7,000
2011-12-01	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,000 sh	$16.74	−$16.7K	6,000
2011-12-01	AVEO PHARMACEUTICALS, INC.Employee Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−1,000 sh	—	—	165,000
2011-11-01	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,000 sh	$5.60	+$11.2K	8,000
2011-11-01	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−2,000 sh	$15.44	−$30.9K	6,000
2011-11-01	AVEO PHARMACEUTICALS, INC.Employee Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,000 sh	—	—	166,000
2011-10-03	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,000 sh	$5.60	+$11.2K	8,000
2011-10-03	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−2,000 sh	$15.43	−$30.9K	6,000
2011-10-03	AVEO PHARMACEUTICALS, INC.Employee Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,000 sh	—	—	168,000
2011-09-01	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,000 sh	$5.60	+$11.2K	8,000
2011-09-01	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−2,000 sh	$16.87	−$33.7K	6,000
2011-09-01	AVEO PHARMACEUTICALS, INC.Employye Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,000 sh	—	—	170,000
2011-08-24	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−1,906 sh	$16.43	−$31.3K	6,000
2011-08-01	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,000 sh	$5.60	+$16.8K	10,906
2011-08-01	AVEO PHARMACEUTICALS, INC.S Sale	Chief Financial Officer	SSale	−3,000 sh	$19.29	−$57.9K	7,906
2011-08-01	AVEO PHARMACEUTICALS, INC.Employye Stock Option (right-to-buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,000 sh	—	—	172,000
2011-02-15	AVEO PHARMACEUTICALS, INC.A Award	Chief Financial Officer	AAward	+6,000 sh	—	—	7,258

Recent filings

Accepted (ET)
Jun 84
Johnston David Brannon0001179110-18-008295
SEC(opens sec.gov)
Mar 164
Johnston David Brannon0001179110-18-004419
SEC(opens sec.gov)
Feb 234
Johnston David Brannon0001179110-18-002674
SEC(opens sec.gov)
Feb 204
Johnston David Brannon0001179110-18-002370
SEC(opens sec.gov)
Feb 234
IMMUNOGEN INC0001179110-17-003018
SEC(opens sec.gov)
Nov 34
IMMUNOGEN INC0001179110-16-031100
SEC(opens sec.gov)
Jul 204
IMMUNOGEN INC0001179110-16-027764
SEC(opens sec.gov)
Sep 214
IMMUNOGEN INC0001104659-15-066207
SEC(opens sec.gov)
Aug 44
IMMUNOGEN INC0001179110-15-011645
SEC(opens sec.gov)
Jul 144
IMMUNOGEN INC0001179110-15-011173
SEC(opens sec.gov)
Jul 184
IMMUNOGEN INC0001179110-14-011834
SEC(opens sec.gov)
Oct 44
AVEO PHARMACEUTICALS INC0001181431-13-052543
SEC(opens sec.gov)

Companies

Address

C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET

CAMBRIDGE, MA, 02139